Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Liraglutide on Body Surface Gastric Mapping

NCT06500130 is registered in ClinicalTrials.gov with Alimetry as lead sponsor.

NCT NCT06500130
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06500130 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Liraglutide on Body Surface Gastric Mapping
Lead sponsor
Alimetry
Phase
Not applicable
Overall status
Completed
Start date
May 30, 2024
Completion date
November 30, 2024
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic nausea and vomiting syndrome, functional dyspepsia, gastroparesis, healthy